Maximilian Koch, Johannes de Jong, Jürgen Glatz, Panagiotis Symvoulidis, Laetitia Lamberts, Arthur L. L. Adams, Mariëtte E. G. Kranendonk, Anton G. T. Terwisscha van Scheltinga, Michaela Aichler, Liesbeth Jansen, Jakob de Vries, Marjolijn Lub-de Hooge, Carolien Schröder, Annelies Jorritsma-Smit, Matthijs Linssen, Esther de Boer, Bert van der Vegt, Wouter Nagengast, Sjoerd Elias, Sabrina Oliveira, Arjen Witkamp, Willem P. Th. M. Mali, Elsken Van der Wall, P. Beatriz Garcia-Allende, Paul van Diest, Elisabeth G. E. de Vries, Axel Walch, Gooitzen van Dam, Vasilis Ntziachristos
In-vivo fluorescently labelled drug (bevacizumab) breast cancer specimen where obtained from patients. We propose a new structured method to determine the optimal classification threshold in targeted fluorescence intra-operative imaging.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.